Sonoma Pharmaceuticals files updated investor presentation highlighting HOCl product portfolio and global reach

Sonoma Pharmaceuticals, Inc.

Presentation covers stabilized hypochlorous acid products for wound, eye, oral, nasal, and dermatological care.
Products sold in 55 countries directly or through distribution partners.
No new financial guidance, specific revenue figures, or material developments disclosed in the presentation.
Company continues to seek new distribution partners for global expansion.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.